2.4. Analysis.
Comparison 2 Anti‐leukaemic therapy with alemtuzumab versus anti‐leukaemic therapy without alemtuzumab (anti‐leukaemic therapy not identical in both groups, confounded), Outcome 4 ORR ‐ subgrouped by alemtuzumab treatment regimen.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.